Concepedia

Erik I. Charych

EI

16

Publications

1.3K

Citations

16

H-Index

2004

Active since

Affiliations

Pfizer (United States)(Current)

University of Connecticut

Rutgers, The State University of New Jersey

Johns Hopkins University

Johns Hopkins Medicine

Erik I. Charych is an author at Pfizer (United States) specializing in medicine, neuroscience, and molecular biology.

Top concepts

Publications per year

2004–2019

16

Publications

16

Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia

Steven M. Grauer, Virginia Pulito, Rachel L. Navarra et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 265 citations

The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function

Q. Wang, Erik I. Charych, Virginia Pulito et al. · Molecular Psychiatry · 2010 · 145 citations · Full text

, , +8

Activity-Independent Regulation of Dendrite Patterning by Postsynaptic Density Protein PSD-95

Erik I. Charych, Barbara F. Akum, Joshua S. Goldberg et al. · Journal of Neuroscience · 2006 · 142 citations · Full text

, , +23

Increased Expression in Dorsolateral Prefrontal Cortex of CAPON in Schizophrenia and Bipolar Disorder

Bin Xu, Naomi S. Wratten, Erik I. Charych et al. · PLoS Medicine · 2005 · 108 citations · Full text

The brefeldin A‐inhibited GDP/GTP exchange factor 2, a protein involved in vesicular trafficking, interacts with the β subunits of the GABA <sub>A</sub> receptors

Erik I. Charych, Wendou Yu, Celia P. Miralles et al. · Journal of Neurochemistry · 2004 · 100 citations

Rows per page

1–5 of 16